Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Multidrug-Resistant (MDR-TB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Not applicableUnknownNCT03827811
What this trial is testing

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
University of Cape Town 625
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT03141060
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 37
Early research (Phase 1)Study completedNCT04493671
What this trial is testing

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 137
Not applicableStudy completedNCT02413931
What this trial is testing

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 53
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Not applicableStudy completedNCT07167823
What this trial is testing

The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront

Who this might be right for
Pleural EmpyemaTuberculosis (TB)Bacterial Sepsis
University of Health Sciences Lahore 350
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Not applicableUnknownNCT03409315
What this trial is testing

Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis, Multidrug-Resistant
University Medical Center Groningen 360
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Large-scale testing (Phase 3)WithdrawnNCT02975570
What this trial is testing

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Who this might be right for
Tuberculosis Multi Drug Resistant Active
Boston University
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Large-scale testing (Phase 3)UnknownNCT02120638
What this trial is testing

Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 100
Next Page